Health Sciences In The Media

The University of Arizona Health Sciences Innovation Building (HSIB) merges state-of-the-art interiors with a tactile terra-cotta façade. The article examines the architectural design of the building through photographs.

Sandy Kurtin, PhD, ANP-C, AOCN, Hematology/Oncology Nurse Practitioner at the University of Arizona Cancer Center and ASH Clinical News Associate Editor, offers advice for promoting interprofessional agility to keep pace with an ever-changing health care environment.

Getting up and going to bed at the same times each day and also trying to stick with consistent eating and exercise routines may help reset their circadian clocks. Another option is to take a low-dose of melatonin — just 0.5 mg — roughly four hours before you typically go to bed. “Melatonin helps tell all the parts of the body what time it is,” says Michael Grandner, PhD, director of the Sleep and Health Research Program at the University of Arizona College of Medicine – Tucson.

The University of Arizona College of Medicine – Tucson earned its best ranking on the U.S. News & World Report diversity index – tied for No. 17 overall and tied for No. 13 among public universities.

Interview with Dr. Jeff Burgess, associate dean for research and professor at the University of Arizona Mel and Enid Zuckerman College of Public Health, who leads the ongoing Arizona HEROES study of 4,000 health care professionals and other front line workers.

Sleep is paramount for healing. A simple bedtime ritual like using a dimmable light which automatically dims to a warm glow over 45 minutes, can help establish that bedtime routine. “The dimming light not only helps your natural melatonin production, but is a reminder to your brain and body to start winding down,” Dr. Michael Grandner, Director of the Sleep and Health Research Program at the University of Arizona Health Sciences.

Even in patients with stage 2 pancreatic cancer, surgery is typically worthwhile after chemotherapy, because it appears to extend patients' lives, a new study in the Journal of the American College of Surgeons concludes. The study was led by Dr. Amanda Arrington, a surgical oncologist at the University of Arizona College of Medicine – Tucson.

Data from ongoing University of Arizona Health Sciences research have confirmed the findings from Phase III clinical trials conducted by Pfizer and Moderna for COVID-19 vaccine approval. The findings, published by the CDC, are the first in the U.S. to measure vaccine effectiveness against both symptomatic and asymptomatic COVID-19 specifically among first responders, health care and frontline workers.

Dr. Shad Marvasti, associate professor with the University of Arizona College of Medicine in Phoenix discusses the current state of COVID-19 in Arizona.

Even after just one dose of the mRNA vaccines made by Pfizer and Moderna, the vaccines reduced the chance of getting infected with SARS-CoV-2, researchers report March 29 in Morbidity and Mortality Weekly Report. “We clearly showed in our study that if you were at least 14 days out from your first shot, you had 80% protection" from infection, said Jeff Burgess, associate dean for research at the Mel and Enid Zuckerman College of Public Health at the University of Arizona.